Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02791399 · ClinicalTrials.gov registry record · NA
A Patient-Centered Intervention to Improve Opioid Safety
A NA study of Chronic Pain and Prescription Opioid Misuse, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 286
- Enrollment target
- 1
- Study location
NCT02791399: Completed NA study of Chronic Pain and Prescription Opioid Misuse, sponsored by VA Office of Research and Development.
NCT02791399 is a NA study of Chronic Pain and Prescription Opioid Misuse that has completed, run by VA Office of Research and Development. The registered enrollment target is 286 participants, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02791399, a NA study of Chronic Pain and Prescription Opioid Misuse, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 286 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized controlled trial of a multifaceted intervention designed to improve the safety of opioid prescribing. The specific aims of this study are to: (a) evaluate whether a multifaceted intervention (Improving the Safety of Opioid Prescribing; ISOP) enhances opioid safety, (b) assess whether participation in ISOP impacts the clinician-patient relationship, and (c) explore to what extent ISOP is associated with changes in pain and pain-related function.
Primary Outcome
The Current Opioid Misuse Measure (COMM) is an assessment of self-reported risk of prescription opioid misuse. There are 17 items, each rated on a scale of 0 (never) to 4 (very often). Total scores range from 0 - 68, with higher scores indicating a greater risk of prescription opioid misuse.
Conditions Studied
Interventions
- BEHAVIORAL ISOP Intervention with the Nurse Care Manager
Study Locations (1)
Oregon
- VA Portland Health Care System, Portland, OR - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 286 participants |
| Start Date | 2016-03-23 |
| Est. Completion | 2020-10-31 |
| Phase | NA |
What the finished NCT02791399 record still lists
NCT02791399 is an interventional study that assigns participants to a tested intervention. The registered 286 participants enrollment target is mid-sized for trials with a published cap, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (63% lower).
The record links to 3 conditions, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which ISOP Intervention with the Nurse Care Manager is the first listed.
NCT02791399 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT02791399 about?
NCT02791399 is a clinical study titled "A Patient-Centered Intervention to Improve Opioid Safety". This is a randomized controlled trial of a multifaceted intervention designed to improve the safety of opioid prescribing. The specific aims of this study are to: (a) evaluate whether a multifaceted intervention (Improving the Safety of Opioid Prescribing; ISOP) enhances opioid safety, (b) assess wh...
What is the current status of trial NCT02791399?
This trial is currently completed. It is a NA study. The enrollment target is 286 participants. The study started on 2016-03-23. Estimated completion is 2020-10-31.
What conditions does trial NCT02791399 study?
This clinical trial studies the following conditions: Chronic Pain, Prescription Opioid Misuse, Opioid Safety.
What interventions are being tested in trial NCT02791399?
The interventions under investigation include: ISOP Intervention with the Nurse Care Manager (BEHAVIORAL).
Who is sponsoring clinical trial NCT02791399?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02791399 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02791399's enrollment target sits among peer trials
286 56th of 301 higher than 246 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04781140 · 286 participants · Phase 4
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- NCT04936529 · 286 participants · Phase 2
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
- NCT05183646 · 286 participants · Phase 3
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- NCT05506878 · 286 participants · NA
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI